Related Experiment Video

Updated: Aug 13, 2026

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

[Stem cell therapy in chronic heart failure]

Hans D Theiss1, Wolfgang-M Franz

  • 1Medizinische Klinik und Poliklinik I der LMU, Klinikum der Universität München--Grosshadern, München.

Medizinische Klinik (Munich, Germany : 1983)
|January 19, 2006
PubMed

Insights

Embryonic stem cells offer a promising future for treating chronic heart failure, potentially regenerating heart tissue when donor organs are scarce. Adult stem cells are in early clinical trials, but embryonic stem cells hold greater regenerative potential.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Context:

  • Growing population of survivors from acute myocardial infarction (heart attack) progressing to chronic heart failure.
  • Limited therapeutic options for end-stage heart failure due to donor organ scarcity.

Purpose:

  • To explore stem cell therapy as a novel strategy for chronic heart failure.
  • To compare the potential of autologous and embryonic stem cells for cardiac repair.

Summary:

  • Current clinical studies investigate autologous stem cells for acute myocardial infarction and chronic heart failure, with uncertain efficacy.
  • Embryonic stem cells, due to their pluripotency and proliferation capacity, are ideal for in vitro tissue engineering.
  • In vitro-generated heart tissue from embryonic stem cells could be transplanted to improve cardiac function in chronic heart failure patients.

Impact:

  • While adult stem cells are in early clinical trials, embryonic stem cells are not yet clinically applied.
  • Embryonic stem cells show significant future potential for treating chronic heart failure and regenerating cardiac tissue.
Abstract

More Related Videos

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.